Zobrazeno 1 - 10
of 112
pro vyhledávání: '"11"'
Autor:
Liangliang Yan, Yanqiao Ren, Kun Qian, Xuefeng Kan, Hongsen Zhang, Lei Chen, Bin Liang, Chuansheng Zheng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectivesTo analyze the clinical outcomes of Transarterial chemoembolization (TACE) for unresectable or “ablation unsuitable” hepatocellular carcinoma (HCC) in the caudate lobe (CL) found at initial presentation in clinical practice.MethodsFifty
Autor:
Jennifer le Guevelou, Vérane Achard, Ismini Mainta, Habib Zaidi, Valentina Garibotto, Igor Latorzeff, Paul Sargos, Cynthia Ménard, Thomas Zilli
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
le Guevelou, J, Achard, V, Mainta, I, Zaidi, H, Garibotto, V, Latorzeff, I, Sargos, P, Ménard, C & Zilli, T 2021, ' PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy : Impact on Treatment Management and Future Directions ', Frontiers in Oncology, vol. 11, 742093 . https://doi.org/10.3389/fonc.2021.742093
Frontiers in Oncology, Vol 11 (2021)
le Guevelou, J, Achard, V, Mainta, I, Zaidi, H, Garibotto, V, Latorzeff, I, Sargos, P, Ménard, C & Zilli, T 2021, ' PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy : Impact on Treatment Management and Future Directions ', Frontiers in Oncology, vol. 11, 742093 . https://doi.org/10.3389/fonc.2021.742093
Biochemical recurrence is a clinical situation experienced by 20 to 40% of prostate cancer patients treated with radical prostatectomy (RP). Prostate bed (PB) radiation therapy (RT) remains the mainstay salvage treatment, although it remains non-cura
Autor:
Suli Yu, Jianqiang Xu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Primary bone lymphoma (PBL) is a less frequent type of extranodal lymphoma, which is defined as a single skeletal tumor or multiple bone lesions without visceral or lymph node involvement. Most published cases have reported diffused large B cell lymp
Autor:
Brage Krüger-Stokke, Helena Bertilsson, Sverre Langørgen, Torill Anita Eidhammer Sjøbakk, Tone Frost Bathen, Kirsten Margrete Selnæs
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectivesThis study aims to prospectively estimate the diagnostic performance of multiparametric prostate MRI (mpMRI) and compare the detection rates of prostate cancer using cognitive targeted transrectal ultrasound (TRUS) guided biopsies, targeted
Autor:
Jiongqiang Huang, Yilian Shen, Biaoda Li, Caiyin Liu, Guangqiu Li, Qingsi Zeng, Yuting Liao, Chen Huai, Renli Cen, Tingfan Wu, Qiuhua Meng
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectivesTo identify the relatively invariable radiomics features as essential characteristics during the growth process of metastatic pulmonary nodules with a diameter of 1 cm or smaller from colorectal cancer (CRC).MethodsThree hundred and twenty
Autor:
Solange Peters, Niklaus Schaefer, Louis Gros, Antonella Diciolla, Martin Hübner, Petr Szturz, Antonia Digklia, Volker Kirchner
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in oncology, vol. 11, pp. 704295
Frontiers in Oncology
Frontiers in oncology, vol. 11, pp. 704295
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The prognosis is often very
Autor:
Stefano Trebeschi, Zuhir Bodalal, Thierry N. Boellaard, Teresa M. Tareco Bucho, Silvia G. Drago, Ieva Kurilova, Adriana M. Calin-Vainak, Andrea Delli Pizzi, Mirte Muller, Karlijn Hummelink, Koen J. Hartemink, Thi Dan Linh Nguyen-Kim, Egbert F. Smit, Hugo J. W. L. Aerts, Regina G. H. Beets-Tan
Publikováno v:
Frontiers in Oncology, 11:609054. Frontiers Media S.A.
Trebeschi, S, Bodalal, Z, Boellaard, T N, Tareco Bucho, T M, Drago, S G, Kurilova, I, Calin-Vainak, A M, Delli Pizzi, A, Muller, M, Hummelink, K, Hartemink, K J, Nguyen-Kim, T D L, Smit, E F, Aerts, H J W L & Beets-Tan, R G H 2021, ' Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy ', Frontiers in Oncology, vol. 11, 609054 . https://doi.org/10.3389/fonc.2021.609054
Frontiers in Oncology
Frontiers in Oncology, 11. FRONTIERS MEDIA SA
Frontiers in Oncology, Vol 11 (2021)
Trebeschi, S, Bodalal, Z, Boellaard, T N, Tareco Bucho, T M, Drago, S G, Kurilova, I, Calin-Vainak, A M, Delli Pizzi, A, Muller, M, Hummelink, K, Hartemink, K J, Nguyen-Kim, T D L, Smit, E F, Aerts, H J W L & Beets-Tan, R G H 2021, ' Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy ', Frontiers in Oncology, vol. 11, 609054 . https://doi.org/10.3389/fonc.2021.609054
Frontiers in Oncology
Frontiers in Oncology, 11. FRONTIERS MEDIA SA
Frontiers in Oncology, Vol 11 (2021)
BackgroundCheckpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patients. Nonetheless, prognostic markers in metastatic settings are still under research. Imaging offers distinctive advantages, providing whole-body infor
Autor:
Mehmet A. Bilen, James F. Jiang, Caroline S. Jansen, Jacqueline T. Brown, Lara R. Harik, Aarti Sekhar, Haydn Kissick, Shishir K. Maithel, Omer Kucuk, Bradley Carthon, Viraj A. Master
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
IntroductionCabozantinib (XL-184) is a small molecule inhibitor of the tyrosine kinases c-Met, AXL, and VEGFR2 that has been shown to reduce tumor growth, metastasis, and angiogenesis. After the promising results from the METEOR and CABOSUN trials, c
Publikováno v:
Frontiers in Oncology. 13
Background: This study performed an overall assessment of the accuracy of ultrasound-guided fine-needle aspiration (FNA) and core needle biopsy (CNB) for detecting axillary lymph nodes in women with breast cancer based on qualified studies.Methods: E
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
This article aims to explain the use of a variety of noninvasive of minimally invasive examinations to obtain reliable diagnostic clues. The choice of treatment methods and repair techniques for wound defects are also critical in terms of the prognos